SIG
IDXX icon

Sargent Investment Group’s Idexx Laboratories IDXX Stock Holding History

Sargent Investment Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Buy
1,330
+5
+0.4% +$2.8K 0.08% 145
2026
Q1 		$745K Hold
1,325
– – 0.1% 127
2025
Q4 		$896K Buy
+1,325
New +$902K 0.11% 122
2025
Q3 		– Sell
-1,424
Closed -$889K – 171
2025
Q2 		$889K Buy
1,424
+1
+0.1% +$478 0.12% 110
2025
Q1 		$598K Buy
+1,423
New +$618K 0.1% 130

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sargent Investment Group's IDXX Position: Q2 2026 in Review

Sargent Investment Group increased its Idexx Laboratories (IDXX) stake by 0.38% in Q2 2026, buying an estimated $2.8K and bringing the position to 1,330 shares worth $700K. The position accounts for 0.08% of the portfolio, ranked #145.

Sargent Investment Group first reported a position in IDXX in Q1 2025 and has held it in 5 quarters since. The position peaked at $896K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sargent Investment Group held 1,330 shares of Idexx Laboratories worth $700K as of Q2 2026.
  • Sargent Investment Group bought 5 Idexx Laboratories shares in Q2 2026, an estimated $2.8K.
  • Idexx Laboratories made up 0.08% of Sargent Investment Group's portfolio in Q2 2026, its #145 holding.
  • Sargent Investment Group first reported a position in Idexx Laboratories in Q1 2025 and has held it in 5 quarters since.
  • Sargent Investment Group's Idexx Laboratories position peaked at $896K in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.